Rank #1254IRWD

Ironwood Pharmaceuticals, Inc.

$4.61

-3.56% (Daily)

Market Cap

$749.95M

Revenue

$338.99M

Rank by MCap

#1254

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

CEO

Mr. Thomas A. McCourt

Headquarters

Boston, MA

Employees

253

About Ironwood Pharmaceuticals, Inc.

Ironwood Pharmaceuticals, Inc., a biotechnology company, focuses on the development and commercialization of therapies for gastrointestinal (GI) and rare diseases in the United States and internationally. It markets linaclotide, a guanylate cyclase type-C (GC-C) agonist for the treatment of adults suffering from irritable bowel syndrome with constipation or chronic idiopathic constipation, as well as for pediatric patients suffering from functional constipation under the LINZESS and CONSTELLA...